CD9 (extracellular) Blocking Peptide (#BLP-NR209) is the original antigen used for immunization during Anti-CD9 (extracellular) Antibody (#ANR-209) generation. The blocking peptide binds and 'blocks' Anti-CD9 (extracellular) primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
Reconstitution
100 ul double distilled water (DDW)
Formulation
Lyophilized Powder.
Accession Number
BLP
Concentration
0.4 mg/ml.
Form
Lyophilized Powder
Notes
Peptide confirmation: Confirmed by amino acid analysis and mass spectrometry Is Toxin: No Standard quality control of each lot: Western blot analysis. Antibodies part of immunogen: (C)EVIKELQEFYKDTYQK, corresponding to amino acid residues 114 - 129 of mouse CD9 Antigen preadsorption control: 1 ug peptide per 1 ug antibody
UNSPSC Code
41105329
Lead Time
1-2 Business Days
Gene Id
12527
Sequence
(C)EVIKELQEFYKDTYQK, corresponding to amino acid residues 114 - 129 of mouse CD9
Target
CD9
Country Of Origin
Israel/IL
Shipping
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C
Purity
>70%
Storage
Storage After Reconstitution: -20°C. Storage Before Reconstitution: Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C